Structure-Activity Relationships and Drug Design
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Oct 25, 2025

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Dong-Hee Koh1, Woo-Seon Song1, Eun-Young Kim2
1Department of Life and Nanopharmaceutical Science, South Korea.
Predicting peroxisome proliferator-activated receptor gamma (PPARγ) antagonists is challenging due to structural diversity. This study introduces a multi-step structure-activity relationship (SAR) screening approach combining three models for improved antagonist prediction.
09:03Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
Published on: March 10, 2020
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: